| Non-interventional Study to Evaluate the Change in Symptoms Scores and Treatment Response After 4 Weeks of Proton-Pump Inhibitors (PPI) Treatment (NCT01103804) | AstraZeneca | 2010-03-01 |
| Esophageal Atresia: Metaplasia, Barrett (NCT02495051) | University Hospital, Lille | 2010-02-01 |
| Observational Study of Anti-Reflux Surgery (NCT01624506) | Torax Medical Incorporated | 2010-01-01 |
| Active Control, Double-blind, Double-dummy, Parallel-group, Randomized Study to Assess the Effect of VECAM 40/300, Administered at Bedtime, vs. Esomeprazole 20 mg, Administered 30-60 Min. Before Dinner, on Daytime and Nighttime GERD Symptoms (NCT01059383) | Vecta Ltd. | 2009-12-01 |
| MSG and Gastrointestinal Motility (NCT01009658) | Gunma University | 2009-12-01 |
| Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) (NCT00992589) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2009-11-01 |
| Assessment of Zegerid on Esophageal pH in Patients With Barrett's Esophagus (NCT01129778) | Stanford University | 2009-11-01 |
| Stimulation of Sensation and Improvement in Swallowing Using Oral Capsaicin (NCT01053286) | University of California, Davis | 2009-10-01 |
| A Pharmacokinetics, Pharmacodynamics and Safety Study of Rabeprazole in New Born Infants With Gastroesophageal Reflux Disease (GERD) (NCT00855361) | Janssen Research & Development, LLC | 2009-07-01 |
| Laparoscopic Sleeve Gastrectomy and Gastroesophageal Acid Reflux (NCT02012894) | University of Turin, Italy | 2009-06-01 |
| Intravenous (IV) Pantoprazole for Gastroesophageal Reflux Disease (GERD) in Neonates and Infants (NCT00744419) | University of Louisville | 2009-05-01 |
| Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux Disease (NCT00847210) | Takeda | 2009-05-01 |
| MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use (NCT01050465) | University of Missouri-Columbia | 2009-05-01 |
| Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor Therapy (NCT00847808) | Takeda | 2009-02-01 |
| Effect of Antireflux Therapy on the Expression of Genes in Patients With GERD (NCT00624546) | University of Rochester | 2009-01-01 |
| Esophageal Bolus Transit in Newborns With Gastroesophageal Reflux Disease (NCT02167984) | University of Turin, Italy | 2009-01-01 |
| ADX10059 as a Monotherapy in Patients With Gastroesophageal Reflux (GERD) (NCT00820079) | Addex Pharma S.A. | 2008-12-01 |
| ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD) (NCT00810485) | Addex Pharma S.A. | 2008-12-01 |
| Effect of Vecam 40/300 and Vecam 20/300 Compared to Omeprazole 20 mg on Gastric pH (NCT00818870) | Vecta Ltd. | 2008-12-01 |
| LINX Reflux Management System Clinical Study Protocol (NCT00776997) | Torax Medical Incorporated | 2008-11-01 |
| A Pharmacokinetic and Relative Bioavailability Study With Rabeprazole Sodium in Healthy Adult Volunteers (NCT01101646) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2008-08-01 |
| An Assessment of pH Testing Methods (NCT01364610) | University of Calgary | 2008-07-01 |
| Practice and Patient Compliance on the PPI (Proton Pump Inhibitors) Treatment of Gastroesophageal Reflux in South Korea (NCT01018160) | Janssen Korea, Ltd., Korea | 2008-06-01 |
| Prevalence of Gastroesophageal Reflux During Childhood and Teenage Years in France (NCT00681837) | AstraZeneca | 2008-05-01 |
| Does Cholecystectomy Increase the Esophageal Alkaline Reflux? Evaluation by Impedance-pH Technique (NCT01047085) | Istanbul University | 2008-04-01 |
| A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn (NCT00627016) | Takeda | 2008-03-01 |
| Pepsin As A Biomarker For Aspiration (NCT00865995) | Medical College of Wisconsin | 2008-02-01 |
| An Efficacy and Safety Study of XP19986 in Subjects With Symptomatic GERD (NCT00557401) | XenoPort, Inc. | 2007-11-01 |
| Study of Changes in Reflux Symptoms and Reflux Finding Score According to Rabeprazole Treatment Period (NCT00614536) | Janssen Korea, Ltd., Korea | 2007-09-01 |
| COPD Patients Diagnosed With GERD,COPD Exacerbations After Treatment With High Dose PPI (NCT00523367) | University of Florida | 2007-08-01 |
| GI Reflux in Lung Transplant and Its Relationship to Chronic Rejection (NCT00455078) | University of Chicago | 2007-06-01 |
| Barrett's Esophagus Related Neoplasia (BERN) Project (NCT00590239) | Midwest Biomedical Research | 2007-05-15 |
| Effect of Acid Reflux on Respiratory Physiology During Exercise in Athletes With GER-Response to Acid Suppression (NCT00444236) | University of Utah | 2007-04-01 |
| Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-adjusted Dosing (NCT00537732) | Matthias Schwab | 2007-04-01 |
| Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment? (NCT00444145) | Vanderbilt University Medical Center | 2007-03-01 |
| Domperidone for Gastroparesis in Solid Organ Transplantation (NCT00552422) | David J. Lederer, M.D. | 2007-03-01 |
| Exhaled Breath Condensate pH in Patients With Cough Caused by Gastroesophageal Reflux (NCT00451841) | University of Massachusetts, Worcester | 2007-03-01 |
| Study Evaluating Pantoprazole in Adolescents With GERD (NCT00367614) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-01-01 |
| Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Non-erosive Reflux or Gastroesophageal Reflux Disease (BY1023/DE-004) (NCT00326027) | Nycomed | 2006-10-01 |
| Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers (NCT00284908) | STEBA France | 2006-09-01 |
| Esophageal and Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux (NCT00373997) | Vanderbilt University | 2006-09-01 |
| Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD) (NCT00365300) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-09-01 |
| Tongue Exercises and Reflux Therapy for Upper Airway Resistance Syndrome (NCT00364481) | West Side ENT | 2006-08-01 |
| Elucidation of Acid-Induced Pulmonary Inflammation (NCT00361972) | University of Utah | 2006-08-01 |
| Proton Pump Inhibitor Therapy for Mild to Moderate Obstructive Sleep Apnea (NCT00211614) | MetroHealth Medical Center | 2006-07-01 |
| Study Evaluating Pantoprazole in Neonates and Preterm Infants With GERD (NCT00362609) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-07-01 |
| Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD) (NCT00300755) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-05-01 |
| Laparoscopic Roux-en-Y Gastric Bypass and Gastro-esophageal Reflux (NCT02618044) | University of Turin, Italy | 2006-05-01 |
| Serial Exhaled Breath pH Monitoring (NCT00330603) | University of Virginia | 2006-04-01 |
| The Influence of Hypnotic Medications on Sleep Arousal and Its Effect on Gastroesophageal Reflux (NCT00462137) | Thomas Jefferson University | 2006-03-01 |
| Esomeprazole and Gastric Emptying of Beer (NCT00472550) | Heidelberg University | 2006-01-01 |
| Longitudinal Study of Children With a Chronic Cough and the Impact of Gastroesophageal Reflux (NCT00771706) | Massachusetts Eye and Ear Infirmary | 2006-01-01 |
| Clinical Trial Comparing Open and Laparoscopic Nissen Fundoplication in Children (NCT00382850) | Johns Hopkins University | 2005-11-01 |
| Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340) (NCT00246909) | Takeda | 2005-11-01 |
| Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD (NCT00259012) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-11-01 |
| Novel Imaging Techniques in Barrett's Esophagus (NCT00576498) | Midwest Biomedical Research | 2005-10-01 |
| Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for Response (NCT00392002) | AstraZeneca | 2005-10-01 |
| Validation of RDQ Questionnaire (NCT00291746) | AstraZeneca | 2005-09-01 |
| Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants. (NCT00226044) | Rijnstate Hospital | 2005-09-01 |
| Famotidine in Subjects With Non-erosive Gastroesophageal Reflux Disease (NCT00141960) | Astellas Pharma Inc | 2005-09-01 |
| German PMS Trial (AWB) to Evaluate Therapy in Reflux Disease and NSAR-Symptoms (NCT00567021) | AstraZeneca | 2005-09-01 |
| Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease (NCT00215787) | Head and Neck Surgery Associates | 2005-09-01 |
| Relationship and Pathophysiology of Gastroesophageal Reflux and Dental/Periodontal Disease (NCT01167543) | University of California, San Francisco | 2005-09-01 |
| Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506) (NCT00261339) | Takeda | 2005-08-01 |
| Study Evaluating Pantoprazole in Children With GERD (NCT00141817) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-08-01 |
| Importance of Non-Acid Reflux in Asthma in Children (NCT00200980) | Nemours Children's Clinic | 2005-08-01 |
| Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid Suppression (NCT00234117) | Ponce Gastroenterology Research | 2005-07-01 |
| Evaluation of Gastroesophageal Reflux in Patients on Continuous Positive Airway Pressure Ventilation for Obstructive Sleep Apnea (NCT00194376) | University of Pennsylvania | 2005-06-01 |
| Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive Esophagitis (NCT00195208) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-06-01 |
| Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339) (NCT00163306) | Takeda | 2005-05-01 |
| Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine - (NCT00229424) | Taiho Pharmaceutical Co., Ltd. | 2005-04-01 |
| HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related Disease (NCT00243724) | AstraZeneca | 2005-04-01 |
| Which Supraesophageal Reflux Symptoms Reliably Respond to Proton-Pump-Inhibitor (PPI) Therapy (NCT00170001) | Mayo Clinic | 2005-04-01 |
| Prospective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese Patients (NCT00517114) | Hospital Authority, Hong Kong | 2005-01-01 |
| Natural History of Gastroesophageal Reflux (GER) in Children < 12 Years of Age (NCT01048840) | Massachusetts General Hospital | 2004-09-01 |
| Natural History of Gastroesophageal Reflux (GER) in Children and Adolescents (NCT00181805) | Massachusetts General Hospital | 2004-09-01 |
| Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms. (NCT00553449) | Janssen-Ortho Inc., Canada | 2004-07-01 |
| Chest Pain Pilot Study (NCT00251901) | AstraZeneca | 2004-05-01 |
| ASTERIX: Low Dose ASA and Nexium (NCT00251966) | AstraZeneca | 2004-05-01 |
| Medical Treatment for Gastroesophageal Reflux Disease (GERD) in Preterm Infants (NCT00131248) | The University of Texas Health Science Center, Houston | 2004-04-01 |
| Quantifying Effects of Treatment of Pediatric Dysphonia (NCT00237679) | University of Wisconsin, Madison | 2004-01-01 |
| Endoscopic Implantation of Enteryx for the Treatment of GERD (NCT00346905) | Beth Israel Deaconess Medical Center | 2003-10-01 |
| A Study of Cisapride in Patients With Symptomatic Gastro-Oesophageal Reflux Disease (NCT01281553) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2003-09-01 |
| Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study (NCT00235677) | UMC Utrecht | 2003-08-01 |
| A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD) (NCT00216489) | Janssen Cilag Pharmaceutica S.A.C.I., Greece | 2003-03-01 |
| Is Laparoscopic Fundoplication Better Than Open Fundoplication in Children ? (NCT01551134) | Oslo University Hospital | 2003-01-01 |
| Comparison of Laparoscopic Hill and Laparoscopic Nissen Anti-Reflux Procedures (NCT01260935) | Swedish Medical Center | 2002-11-01 |
| On Demand Treatment of Reflux Disease (NCT00184522) | Norwegian University of Science and Technology | 2002-08-01 |
| Safety and Efficacy of Lansoprazole in Patients With Reflux Disease (NCT01135368) | Takeda | 2002-06-01 |
| Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus (NCT00431756) | Johns Hopkins University | 2002-05-01 |
| Esomeprazole (NEXIUM) vs. Surgery (NCT00251927) | AstraZeneca | 2001-10-01 |
| A Study of Efficacy and Safety of "On-demand" Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD) (NCT00236392) | Janssen Pharmaceutica N.V., Belgium | 2001-10-01 |
| Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERD (NCT02670642) | AstraZeneca | 2001-08-01 |
| Laparoscopic Nissen Versus Anterior Partial Fundoplication (NCT01669330) | Region Skane | 2001-01-01 |
| A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication Treatment of Patients With Chronic GERD (NCT00182260) | McMaster University | 2000-01-01 |
| Laparoscopic Nissen Fundoplication Comparing Division Versus Non-Division of Short Gastric Vessels (NCT00852098) | Federal University of São Paulo | 1997-11-01 |
| Functional and Molecular Characterisation of Oesophageal Distal Epithelium: Correlations With Acid and Non Acid Reflux (NCT00231881) | Nantes University Hospital | |
| Medical and Surgical Treatment of Esophageal Reflux (NCT00061724) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |
| A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime Heartburn (NCT00237367) | PriCara, Unit of Ortho-McNeil, Inc. | |
| Influence of Hygiene-dietetic Habits and Treatment Adherence on the Effectiveness of the Gastroesophageal Reflux Illness Treatment With Rabeprazol (NCT00511966) | Janssen-Cilag, S.A. | |